Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions 
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push 
BURLINGTON, Mass., May 11, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Investor Conference in Boston on Wednesday, May 17, 2017 at the Boston Park Plaza. The Company’s presentation is scheduled to begin at 10:00 AM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, June 1, 2017 at the Palmer House Hilton in Chicago, IL.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6, 2017 at the Grand Hyatt in New York, NY. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]
